Patent · US Revoked

Nanoparticulate megestrol formulations

US9044396B2 · kind B2 · utility

0Cited by
81References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 29, 2004
Grant dateJun 2, 2015
Priority date
Expiry dateAug 19, 2027

Classification

  • Technology area (CPC —)General

Abstract

The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.